Department of Retina, Sri Venkateswara Aravind Eye Hospital, Tirupathi, Andhra Pradesh, India.
Indian J Ophthalmol. 2022 Sep;70(9):3420-3422. doi: 10.4103/ijo.IJO_861_22.
A few cases of posterior uveitis following COVID-19 vaccination have been reported but none in the pediatric age group. A 15-year-old girl presented with history of headache and bilateral blurred vision of five days duration. The symptoms developed five days after vaccination with the first dose of Covaxin (inactivated SARS-CoV-2 vaccine). Her anterior segment was normal in both eyes (BE), whereas the posterior segment showed mild vitritis with disc edema and multiple yellowish lesions at the level of choroid clustered at the macula and associated with multiple serous detachments. BE uveitis resolved, and the vision was completely recovered three weeks after treatment with steroids. Hence, ophthalmologists should be aware of uveitis following vaccination-a condition that is usually benign, transient, and results in excellent outcomes with timely diagnosis and early treatment with steroids.
有几例 COVID-19 疫苗接种后发生后葡萄膜炎的病例报告,但在儿科年龄组中没有报告。一名 15 岁女孩因头痛和双眼视力模糊五天前来就诊。这些症状在接种第一剂 Covaxin(灭活 SARS-CoV-2 疫苗)五天后出现。她双眼眼前段正常(BE),但后段显示轻微的虹膜炎,伴有视盘水肿和脉络膜水平的多个黄色病变,聚集在黄斑区并伴有多个浆液性脱离。在类固醇治疗三周后,BE 葡萄膜炎消退,视力完全恢复。因此,眼科医生应该意识到疫苗接种后的葡萄膜炎——这种情况通常是良性的、短暂的,并且通过及时诊断和早期类固醇治疗可以获得极好的结果。